Abstract This study details the rational design and synthesis of benzimidazole–1,2,3-triazole hybrids (10a-10o) as potential CDK2 inhibitors for anticancer treatment. Molecular docking showed strong binding within the ATP-binding site, with key hydrogen bonds to Leu83 and Asp86, as well as hydrophobic and π–π interacti...
Dharmesh A. Patel, R. Dabhi, Apurva Prajapati et al.· Synthetic Communications· 0 citations
1,3,4-oxadiazole-2-thiol derivatives are established as promising dual-action therapeutic scaffolds for anticancer and antibacterial activities through computational and experimental approaches.
Ila M. Ram, Jay B. Maheta, Darshna K. Lakhnotra et al.· Future Medicinal Chemistry· 0 citations
Findings identify 10d as a promising scaffold for further optimization and biological evaluation because it has the smallest HOMO-LUMO gap and highest chemical softness, consistent with its superior activity.
Prince A. Dave, Jay B. Maheta, Darshna K. Lakhnotra et al.· Organic and biomolecular che...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.